Vident Investment Advisory’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-107,144
| Closed | -$195K | – | 1255 |
|
|
2023
Q1 | $195K | Sell |
107,144
-2,954
| -3% | -$5.38K | 0.01% | 1109 |
|
|
2022
Q4 | $558K | Sell |
110,098
-85,029
| -44% | -$431K | 0.02% | 670 |
|
|
2022
Q3 | $969K | Sell |
195,127
-20,846
| -10% | -$104K | 0.03% | 601 |
|
|
2022
Q2 | $804K | Buy |
215,973
+14,385
| +7% | +$53.6K | 0.02% | 699 |
|
|
2022
Q1 | $1.13M | Buy |
201,588
+33,112
| +20% | +$186K | 0.03% | 640 |
|
|
2021
Q4 | $1.02M | Buy |
168,476
+70,722
| +72% | +$430K | 0.03% | 697 |
|
|
2021
Q3 | $952K | Sell |
97,754
-6,982
| -7% | -$68K | 0.03% | 695 |
|
|
2021
Q2 | $1.5M | Buy |
+104,736
| New | +$1.5M | 0.05% | 521 |
|
|
2018
Q2 | – | Sell |
-359,420
| Closed | -$1.45M | – | 935 |
|
|
2018
Q1 | $1.45M | Buy |
359,420
+97,406
| +37% | +$392K | 0.06% | 344 |
|
|
2017
Q4 | $1.18M | Buy |
262,014
+75,201
| +40% | +$338K | 0.05% | 357 |
|
|
2017
Q3 | $1.02M | Buy |
186,813
+5,661
| +3% | +$31K | 0.06% | 365 |
|
|
2017
Q2 | $1.38M | Buy |
181,152
+42,461
| +31% | +$322K | 0.11% | 286 |
|
|
2017
Q1 | $492K | Buy |
138,691
+23,112
| +20% | +$82K | 0.05% | 333 |
|
|
2016
Q4 | $661K | Buy |
115,579
+13,732
| +13% | +$78.5K | 0.08% | 320 |
|
|
2016
Q3 | $792K | Sell |
101,847
-653
| -0.6% | -$5.08K | 0.11% | 310 |
|
|
2016
Q2 | $638K | Buy |
102,500
+12,056
| +13% | +$75K | 0.09% | 347 |
|
|
2016
Q1 | $744 | Buy |
90,444
+42,208
| +88% | +$347 | 0.05% | 360 |
|
|
2015
Q4 | $836K | Buy |
+48,236
| New | +$836K | 0.11% | 325 |
|